Close Menu

NEW YORK – Biocept filed a preliminary prospectus with the US Securities and Exchange Commission today for an offering of $13.8 million in shares of its common stock, coupled with warrants to purchase additional shares.

The company has not yet priced the offering but said that each stock share will come with a warrant to purchase one additional share. Warrants will be immediately exercisable and will expire on the fifth anniversary of the original issuance date.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a cartoon, Vox explores the lack of women among this year's winners of the Nobel Prize.

Science reports a new US defense bill would establish two groups aimed at combating foreign influence on research. 

Nature Biotechnology discusses promising early results from two clinical trials of CRISPR-based therapy for β-thalassemia and sickle cell disease.

In Cell this week: analysis of tissue clones, metagenomic studies of ocean water samples, and more.